InsiderTrades

Form 4 for RXST RxSight, Inc.

Accepted 2024-07-12 00:00:00 ET · period of report 2024-07-11 · accession 0000950170-24-083334 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-12 2024-07-11 RXST Kurtz Ronald M MD Pres, CEO, Dir M - OptEx $15.08 +13.5K 53.5K +34% +$203.6K
D 2024-07-12 2024-07-11 RXST Kurtz Ronald M MD Pres, CEO, Dir M - OptEx $0.00 -13.5K 26.8K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-11 M A 13,500 $15.08 53,500 D — —
2 Derivative Stock Option (right to buy) 2024-07-11 M D 13,500 $0.00 26,836 D $15.08 · — to 2030-04-22 13,500 Common Stock (F2) Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the "2015 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2015 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. The option originally covered 500,000 shares of common stock pre 10.33 for 1 reverse split shares.